NIH to study malaria drug championed by President Trump against COVID-19

The National Institutes of Health (NIH) said on Thursday it began a study to evaluate the combination of antibiotic azithromycin and malaria drug hydroxychloroquine, which was previously touted by U.S. President Donald Trump as a "game changer", for the treatment of COVID-19.